iCAD (ICAD) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
iCAD Reports Financial Results For Second Quarter 2022
August 10, 2022 4:07 PM EDTCompany reports accelerating demand for subscription and cloud-based business models driving long-term recurring revenue opportunities
Cancer Detection revenue grew 10.4% compared to the second quarter of 2021
Company to host conference call and webcast today at 4:30 PM ET
NASHUA, N.H., Aug. 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today... More
